Cancer

The death rates for most forms of cancer continue to decline at a modest pace among men, women and children in the United States, according to the Annual Report to the Nation on the Status of Cancer 1975 – 2011. Read More

Vanderbilt University researchers have discovered a cleft in a chromosome-binding protein that may hold the key to stopping most cancers in their tracks. Read More

Improvements in cancer diagnosis and treatment have led to longer survival for most cancer patients in the United States. However, the improvement in survival was substantially greater among younger patients and those who are white in most of the cancers studied, according to new research by Vanderbilt University investigators. Read More

Mechanical stress appears to be a critical factor in activating normal tissue-associated fibroblasts to generate cancer-associated fibroblasts. Read More

A specific gene expression profile represents a novel, biologically relevant “signature” for identifying colon cancers with high risk of metastatic recurrence, Vanderbilt researchers have found. Read More

Prospecting for genes that might be implicated in cancer, a Vanderbilt University Medical Center research team has struck pay dirt. Read More

In the latest VUCast: See a powerful new weapon in the fight against malaria and how a 3-D printer speeds up the research; meet a little dog that won a big award; and hear the Melodores, winners of NBC's "The Sing-Off." Watch now! Read More

A protein that degrades the “matrix” between cells participates in the development of lung metastases from primary breast cancer in mouse models and may be a good target for breast cancer treatment. Read More

A new mouse model offers insight into the signaling pathways that control oral cancers – and a platform for testing anticancer therapeutics. Read More

Vanderbilt investigators have used a computational biology approach to uncover new cancer drivers and biomarkers of anticancer drug response. Read More

Terrah Foster Akard, Ph.D., M.S.N., R.N. The Vanderbilt University School of Nursing (VUSN) has been awarded a $1.8 million grant by National Institute of Health/National Institute of Nursing Research. The four-year grant is in partnership with the Palliative Care Research Cooperative (PCRC), and will recruit children with… Read More

Two writing workshops are scheduled to begin in October. Both are collaborations of the Vanderbilt-Ingram Cancer Center, the Vanderbilt Oncology Expressive Arts Committee and the Curb Center for Art, Enterprise and Public Policy at Vanderbilt. Read More

Longtime patient advocate and breast cancer survivor Pam Martin is the 2014 recipient of the Nancy Saturn Award of Inspiration from Gilda’s Club Nashville, an affiliate of the Cancer Support Community. Read More

A subpopulation of bone cancer cells may be responsible for driving clinically aggressive behavior, suggesting new treatment options. Read More

Understanding how to control the generation of regulatory T cells could have important implications for treating autoimmunity and cancer. Read More

It all started with a faint glow. It was November 1895, and the German physicist Wilhelm Roentgen was experimenting with an early cathode ray tube—a vacuum tube with a contained electric current. During his experiments he noticed an odd fluorescence in crystals on a nearby table. Surprisingly, the glow continued even… Read More

Vanderbilt continues to win recognition for its commitment to helping employees stay healthy, including support for activities that may protect against cancer. Vanderbilt University Medical Center (VUMC), in conjunction with Vanderbilt-Ingram Cancer Center (VICC), has been re-accredited as a CEO Cancer Gold Standard employer for 2014. In 2001, former President… Read More

New Vanderbilt research suggests patients with advanced melanoma — the most deadly form of skin cancer — could safely benefit from a combination of immunotherapy and targeted therapies aimed at specific gene mutations. Read More

The contractile machinery inside tumor cells increases invasive properties, suggesting it might be a good target to inhibit cancer cell spread. Read More

A novel PET imaging probe detects tumor cell death in vivo and could be useful for personalizing cancer medicine. Read More